Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00SVP
|
||||
Former ID |
DIB006508
|
||||
Drug Name |
PF-4455242
|
||||
Synonyms |
PF-04455242
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bipolar disorder [ICD9: 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300; ICD10:F31, F40-F42] | Phase 1 | [522809] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H29ClN2O2S
|
||||
Canonical SMILES |
CC(C)CNCc1ccc(cc1)c2ccccc2S(=O)(=O)N3CCCC3
|
||||
InChI |
1S/C21H28N2O2S/c1-17(2)15-22-16-18-9-11-19(12-10-18)20-7-3-4-8-21(20)26(24,25)23-13-5-6-14-23/h3-4,7-12,17,22H,5-6,13-16H2,1-2H3
|
||||
InChIKey |
OWVIKBRKPCTDEP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Modulator | [531552] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.